 If no company produces a vaccine that meets the predetermined standards, governments (and thus their taxpayers) spend nothing.For the bio-pharmaceutical industry, AMCs create a guaranteed market, with a promise of returns that would not normally exist.For developing countries, AMCs provide funding to ensure that those vaccines will be affordable once they have been developed.